Literature DB >> 6344841

Splenectomy and death in renal transplant patients.

T G Peters, J W Williams, H C Harmon, L G Britt.   

Abstract

To determine any association of splenectomy and death, 191 recipients of a single renal transplant were reviewed. Pretransplant splenectomy was performed in 90(47%) patients and the spleen was retained ("spleen-retaining") in 101 (53%). Sixty-eight patients (36%) died. Thirty-two fatal infections occurred in asplenic patients compared with ten infection-caused deaths in those retaining the spleen; 12 asplenic and 14 spleen-retaining patients died of noninfectious causes. Age, sex, graft source, HLA mismatch, and period of graft function were similar in asplenic and spleen-retaining patients who died. Prospective, multicenter, and single-center studies support divergent conclusions regarding the risks and benefits of splenectomy in transplantation. Study of specific center experience should precede adopting a policy of pretransplant splenectomy, an irreversible form of immunosuppression significantly related to fatal infection.

Entities:  

Mesh:

Year:  1983        PMID: 6344841     DOI: 10.1001/archsurg.1983.01390070007002

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  4 in total

1.  Partial splenic embolization: experience in 136 patients.

Authors:  O Jonasson; D G Spigos; M F Mozes
Journal:  World J Surg       Date:  1985-06       Impact factor: 3.352

2.  Cadaver donor renal transplantation by centers of the South-Eastern Organ Procurement Foundation. The prospective study after 6.5 years and 3811 allografts.

Authors:  J C McDonald; W Vaughn; R S Filo; G Mendez-Picon; G Niblack; E K Spees; G M Williams
Journal:  Ann Surg       Date:  1984-10       Impact factor: 12.969

3.  [Risk of infection following splenectomy].

Authors:  J Seifert; S Brieler; F Reese; H Hamelmann
Journal:  Langenbecks Arch Chir       Date:  1986

4.  Role of splenectomy in human liver transplantation under modern-day immunosuppression.

Authors:  F Samimi; W D Irish; B Eghtesad; A J Demetris; T E Starzl; J J Fung
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.